What caused the spike in AIFF stock today?

AIFF stock surged after company releases reported rapid partner growth and a larger EEG/ERP dataset. Heavy retail buying and short-covering pushed volume to **308,269,775** shares, producing the 126.28% gain.

How does Meyka AI grade AIFF stock?

Meyka AI rates AIFF with a score of **63.18** out of 100, graded **B** and suggested as **HOLD**. The grade factors in benchmark and sector comparisons, financial growth, key metrics, and analyst signals.

What is the short-term technical outlook for AIFF stock?

Short-term, AIFF stock is overbought with RSI **81.88** and ADX **38.62**. Watch support at **$0.98** and resistance near **$1.89**. A sustained drop in volume could trigger sharp pullbacks.

What price could AIFF stock reach in a year?

Meyka AI's model projects **$3.45** in one year, implying about **122.63%** upside from **$1.55**. This is a model projection and not a guarantee; fundamentals and liquidity present meaningful risk.

US Stocks

AIFF Firefly Neuroscience (NASDAQ) jumps 126.28% on 04 Mar 2026: confirm trend with record volume

ByDanny Kontos March 5, 2026

AIFF stock jumped 126.28% to $1.55 on 04 Mar 2026. Trading closed with 308,269,775 shares, about 2,440.98 times average volume. The spike followed company updates on commercial growth and its EEG/ERP foundation model. Firefly Neuroscience, Inc. (AIFF) traded on the NASDAQ in the United States, moving from a prior close of $0.69. Today’s action puts liquidity and momentum squarely in focus for traders and analysts tracking small-cap medical AI names.